reservoir. Using green fluorescent protein (GFP) reporter strains of HIV-1 and multi parameter flow cytometry, we developed an assay to simultaneously quantify the susceptibility of stem memory (TSCM), central memory, effector memory, transitional memory and naï ve CD4 + T cell subsets, to HIV-1 infection in vitro. We show that TSCM are susceptible to infection with laboratory adapted and clinical HIV-1 strains. Our system facilitates the quantitation of HIV-1 infection in alternative T cell subsets by CCR5-and CXCR4-using viruses across different HIV-1 subtypes, and will be useful for studies of HIV-1 pathogenesis and viral reservoirs.
Introduction
Memory T cells play an important part of the adaptive immune response to infection [1] [2] [3] . Upon antigen encounter, naï ve T cells undergo proliferation and differentiation into different memory T cell subsets which culminate into terminally differentiated effector T cells [4, 5] . During the process of maturation, T cells progressively acquire effector functions but also lose the capacity for self-renewal and survival [1] . A small proportion of memory T cells survives the contraction phase and become long-lived memory T cells which have the ability to rapidly acquire effector functions upon reinfection [3, 4] .
Memory CD4 + T cells have conventionally been divided into central memory (CM) and effector memory (EM) based on their surface receptor expression (CCR7, CD62L) and the level and type of cytokine secretion (IFN-γ, IL-2, IL-4) [6, 7] . CM CD4 + T cells are relatively long-lived memory cells which are able to undergo differentiation into a shorter lived EM T cells upon antigen stimulation [1, 5, 7] and, although to a lesser extent, in response homeostatic cytokines (for example IL-7 and IL-15) [8, 9] . Transitional memory (TM) CD4 + T cells have functional and transcriptional characteristics which are in between those of CM and EM T cells [10] and can be distinguished through the additional use of CD27 surface receptor expression [8] . More recently a novel T cell subset, stem memory T cells (TSCM) has been detected in both CD4 + and CD8 + T cell populations in humans and nonhuman primates [11, 12] . This novel T cell subset comprises ~2 %-3% of the CD4 + and CD8 + T cell population in healthy individuals, and exhibits a gene profile between naï ve and CM T cells [11, 12] . These cells constitute a small proportion of the memory T cell subset and display stem cell-like properties, representing the earliest and longest lasting developmental stage of memory T cells [12] . TSCM cells display common surface markers characteristic of naï ve T cells (CD45RA ), but can be distinguished from naï ve T cells by high expression of CD95 and CD122 (IL-2R) on their cellular surface, markers which are also expressed by memory T cell subsets [11] . TSCM are antigen-experienced and upon TCR stimulation, exhibit effector activity and are able to differentiate into CM and EM subsets. They have the ability to self-renew in the presence of IL-15 homeostatic signals, and are able to survive for longer periods than CM or EM populations [12] .
Previous studies have demonstrated the importance of memory T cells in immune responses to viral infections [2, 13] . In HIV-1, CD4
+ T cells are a key target of infection, where depletion of these cells results in deterioration of the immune system and progression to AIDS [14, 15] . Importantly, both CM and TM CD4 + T cell subsets have been demonstrated as major HIV-1 cellular reservoirs where the maintenance of these reservoirs is associated with T cell survival and homeostatic proliferation (antigen-driven and IL-7-mediated, respectively) [8] . Additionally, the TSCM subset has been demonstrated to support long-lived T cell memory, with the potential to be a cellular reservoir of HIV-1 [12, 16, 17] . Preliminary studies have demonstrated promising results for TSCM with a particular interest in the role of these cells in cancer and HIV-1. In mouse models, TSCM have exhibited increased anti-tumor activity and are being considered for adoptive T cell therapies for cancer patients [1, 12, 18] . Importantly for HIV-1 research, recent studies [17] have demonstrated CD4 + TSCM to contain high per-cell levels of HIV-1 DNA and contribute to the total CD4 + T cell reservoir. Thus, long-lived TSCM have the potential to promote HIV-1 viral persistence [17, 19] . The cellular tropism of HIV-1 can influence the size and composition of the viral reservoir, with particular CD4 + T cell subsets described as cellular reservoirs for HIV-1 [8, 20] . How the cellular tropism of HIV-1 for different T cell subtypes alters during disease pathogenesis is largely unknown. Thus, the development of an assay system which has the ability to detect changes in HIV-1 tropism for T cells during disease pathogenesis, and also characterizes changes in tropism between CCR5-and CXCR4-using viruses is important for the design of new therapeutic targets and for characterizing the cellular reservoir of HIV-1.
Results and Discussion

Development and Validation of a T Cell Assay for the Detection of Infected TSCM
We previously developed an assay to quantify HIV-1 infection in non-TSCM CD4 + T cell subsets in vitro [21] . This assay detected and quantified HIV-1 infection in CM, TM, EM, naï ve and effector memory RA (EMRA) CD4 + T cells [21] . In this previous system the CD4 + T cells were activated with anti-CD3 and anti-CD28 (5 μg/mL) prior to infection with Env-pseudotyped GFP reporter viruses. The CD4 + T cells were cultured in media supplemented with IL-2 (20 U/mL) at all stages of the experiment (described in [21] ). Since the recent description of TSCM cells, we have developed a new assay system which incorporates quantitation of HIV-1 infection in the TSCM subset. TSCM cells are the least differentiated of the memory T cell populations [11] . They express many naï ve markers and are relatively rare, comprising approximately 2%-4% of the total CD4 + T cells in the blood [11] . They can be differentiated from naï ve T cells by the use of the memory marker CD95 and CD122 [11] . In developing the new assay, we first ensured detection of all CD4 + T cell subsets in uninfected CD4 + T cells from peripheral blood using a panel of cytometry antibodies (Table 1, Figure 1 ). * A fixable viability dye was chosen so the HIV-1 infected cells would also be fixed. ^ CD27 has been chosen over CD62L as expression of CD62L is not reliable on cryopreserved cells [22] .
# CCR5 and CXCR4
antibodies used for HIV-1 infected samples.
Because TSCM share cellular markers with naï ve T cells and are a relatively rare population, we proposed that the activation of CD4 + T cells prior to infection in our in vitro system may not accurately depict HIV-1 infection of this subset. Therefore, to examine the effect of stimulating CD4 + T cells prior to infection and the effect of the addition of IL-2 to the assay, we performed experiments with both stimulated (plates coated with anti-CD3 and anti-CD28) and unstimulated cells in the presence and absence of IL-2 ( Figure 2 ). As expected, without anti-CD3 and anti-CD28 stimulation, and without the addition of IL-2, there was lower T cell infectivity (Figure 2A ), however there was also a slight increase in the detection of HIV-1 infected TSCM ( Figure 2C ). There was little change in the proportion of CD4 + T cell subsets infected with or without prior stimulation or the addition of IL-2 ( Figure 2B ), thus we chose not to stimulate the CD4 + T cells in future experiments.
We next performed time course experiments to determine the optimal time to infect the CD4 + T cells after isolation. We examined cell viability, infection levels and consistency of T cell subsets infected ( Figure 3 ). These assays confirmed good viability, reproducible infection levels and the greatest consistency with infection of CD4 + T cell subsets when infection was on the same day of isolation (day 0) or 24 hours post isolation (day 1, Figure 3A ,C-E). We also ensured T cell subset proportions of no virus control wells represented CD4 + T cell subset starting populations ( Figure 3B ).
In all conditions the susceptibility of each T cell subset to infection remained consistent. CM cells were the most susceptible to infection by JR-CSF followed by TM, EM, naï ve, TSCM and EMRA cells ( Figure 3F ). Due to the short assay duration (72 hours) and the choice of flow cytometry antibodies for detection of TSCM including CD122 (IL-2Rβ Table 1 ), we chose not to add IL-2 to the assay at any stage and chose to infect the CD4 + T cells one hour post-isolation for the experimental protocol. + T cells. This gating strategy allowed EM to be distinguished from TM, similar to methods used by other investigators [8] and as we have described previously [21] . The use of an additional cellular marker, CD27, also enabled better enumeration of T cell subsets, as described previously [23, 24] . TSCM were identified using methods similar to those described previously [11] . 
HIV-1 Infection in CD4 + T Cell Subsets by CCR5-and CXCR4-Using Viruses
We next confirmed that we could detect and measure HIV-1 infection of the CD4 + T cell subsets by both CCR5-and CXCR4-using viruses. The strategy for detecting HIV-1 infection in the different T cell subsets is illustrated in Figure 4 . We used the well characterized JR-CSF (CCR5-using) and HXB2 (CXCR4-using) Envs to produce Env-pseudotyped GFP reporter viruses, to examine CD4 + T cell subset tropism and infectivity. JR-CSF and HXB2 are frequently used as controls in HIV-1 experiments. Both viruses are derived from patient isolates and are subtype B HIV-1. JR-CSF and HXB2 have been demonstrated to be T cell tropic [21, 25, 26] .
Prior to infection we examined the level of CCR5 and CXCR4 expression on all CD4 + T cell subsets from five healthy donors. CD4 expression from the five donors was similar across all T cell subsets (as previously reported [21] , and data not shown). CCR5 expression varied between T cell subsets with the highest expression on EM and TM cells (17 +/− 5% and 14 +/− 6%, respectively), a moderate expression on CM cells (9 +/− 5%), lower expression on TSCM (6 +/− 5%) and very low expression on naï ve and EMRA (both 1 +/−1 %). CXCR4 expression was high on all T cell subsets (>70%) with the highest expression on naï ve T cells (90 +/− 5%). The distribution of CD4, CCR5 and CXCR4 expression across the T cell subsets was similar to that reported previously for peripheral blood CD4 + T cell subsets [21, [27] [28] [29] . cell subset tropism between JR-CSF and HXB2, likely due to their difference in use of co-receptor for viral entry ( Figure 5 ). The CCR5-using JR-CSF preferentially infected memory T cell subsets, in particular CM (mean 26.60 +/− 6.23%) and TM (mean 20.00 +/− 7.84%) with a lower level of infection for naï ve T cells (mean 12.00 +/− 5.52%, Figure 5A ). In contrast, the CXCR4-using HXB2 preferentially infected naï ve T cells (mean 25.13 +/− 2.00%) with a lower level of infection in memory T cell subsets (CM mean 13.11 +/− 2.85%, TM mean 12.35 +/− 2.57%, Figure 5A ). Both JR-CSF and HXB2 were able to infect a similar proportion of TSCM cells (JR-CSF mean 7.80 +/− 5.07%, HXB2 mean 6.32 +/− 1.65%, Figure 5A ). ). TSCM were identified using methods similar to those described previously [11] . Percentages represent the percent of the parent population gated. The preferential infection of memory T cell subsets by the CCR5-using JR-CSF could be facilitated by high expression of the co-receptor CCR5 on these subsets [21, [27] [28] [29] . Similarly, the preferential infection of naï ve T cells by the CXCR4-using HXB2 may have been facilitated by naï ve T cells expressing higher levels of CXCR4 [27, 28] . Both JR-CSF and HXB2 infected a similar proportion of TSCM cells, approximately 6%-7%; this level of infectivity by the CCR5-using JR-CSF could be contributed to by TSCM expressing a low level of CCR5 compared to other memory T cell subsets (reported above). It is perhaps not surprising that the CXCR4-using HXB2 infected a proportion of TSCM, as this virus can infect other memory CD4 + T cell subsets. Figure 5B ). The overall percentages of TSCM infected by JR-CSF and HXB2 were similar; suggesting that it is the number of naï ve T cells infected which increases with CXCR4-using viruses compared to CCR5-using viruses. Infection of TSCM by CCR5-and CXCR4-using viruses in vitro has not been previously reported. This finding, combined with the reported potential of TSCM to be a long-lived reservoir for HIV-1 [12, 16] , is potentially important for the development of therapeutics targeting the HIV-1 reservoir for both CCR5-and CXCR4-using viruses. It is also important knowledge for therapies targeting subtype B HIV-1 strains, as approximately 40%-50% of subtype B viruses undergo a co-receptor switch during progression to advanced stages of infection [30, 31] , suggesting infection of TSCM could potentially be maintained throughout HIV-1 disease progression.
Measurement of Infection in CD4 + T Cell Subsets by HIV-1 Subtype C Viruses
We next tested the assay system using GFP reporter viruses pseudotyped with CCR5-using HIV-1 Envs isolated from two subjects infected with HIV-1 subtype C (subjects 258 and 1136). These Envs, and the clinical characteristics of the subjects have been described in detail recently [32, 33] . The Env clones from subject 258 used here were 258-E-5, 258-E-6, 258-E-20 and 258-E-23, and those from subject 1136 were 1136-E-1, 1136-E-4, 1136-E-11 and 1136-E-12 [32, 33] . All of the subtype C Envs exclusively used the CCR5 co-receptor [21, 22] . CD4 + T cells from five healthy donors were used to determine CD4 + T cell subset tropism of these viruses ( Figure 6 ), using the strategy outlined in Figure 6A -C). Viruses from both subjects 258 and 1136 infected a similar proportion of TSCM (7 and 5% respectively), naï ve T cells (16 and 13% respectively) and a lower proportion of EMRA cells (1%, Figure 6D-F) .
Infection of the CD4 + T cell subsets by the subtype C viruses was similar to the trends shown by Envs from subject 258 and four from subject 1136, as described in the Experimental section. The percentage of infection for each CD4 + T cell subset was determined and quantified by flow cytometry (as shown in Figure 4 ). These CCR5-using viruses preferentially infected (B) TM and (C) CM T cells (mean level >17% infection), with a modest level of infection was seen in (A) EM (mean >8%), (D) TSCM (mean >5%) and (E) Naï ve T cells (mean >13%). (F) EMRA were rarely infected (mean 1%). Scatter plots represent the median and interquartile range.
Experimental Section
Cells
293T cells, JC53 cells [34] and TZM-bl cells [35] were maintained as described previously [21] . Peripheral blood mononuclear cells (PBMC) were purified from the blood of healthy HIV-1 negative donors by density gradient centrifugation.
HIV-1 Env Clones
All Envs used in this study are expressed from the pSVIII-Env mammalian expression plasmid [36] . For assay validation and as controls for each assay, the well characterized CCR5-using JR-CSF Env and CXCR4-using HXB2 Env were used, as described previously [21, 25, 26] . The HIV-1 subtype C Envs are derived from plasma of two subjects (subjects 258 and 1136) with chronic subtype C infection [33] . Four independent Envs from each subject were used in this study. The Env clones from subject 258 were 258-E-5, 258-E-6, 258-E-20 and 258-E-23, and those from subject 1136 were 1136-E-1, 1136-E-4, 1136-E-11 and 1136-E-12 [32, 33] . These Envs were shown to be specific for the CCR5 co-receptor by phenotypic entry assays [33] and also by the recently developed CoRSeq V3-C co-receptor usage prediction algorithm, that was designed specifically for HIV-1 subtype C Envs [37] .
Production and Quantitation of Env Pseudotyped GFP Reporter Viruses
Env pseudotyped, GFP reporter viruses were produced as described previously [21] . Briefly, 293T cells were transfected with pNL4-3Env-GFP [38] and pSVIII-Env plasmids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) at a ratio of 4:1. Supernatants were harvested 48 h later and filtered through 0.45 μm filters. Viruses were concentrated through a 20% (vol/vol) sucrose cushion, and stored at −80 °C. The TCID 50 of virus stocks was determined by titration in TZM-bl cells, as described previously [35, 39] .
Enumeration of HIV-1 Infection in CD4 + T Cell Subsets
Forty-eight well tissue culture plates were seeded with 500 μL of 4 × 10 6 /mL of purified CD4 + T cells (2 × 10 6 cells in each well) that were isolated from healthy donors using a RosetteSepCD4 + T-cell kit [Stemcell Technologies (Vancouver, BC, Canada), >95% purity of CD3 + CD4 + T cells in each experiment]. Cells were suspended in RPMI 1640 medium containing 10% (vol/vol) FCS at all stages of the experiment. CD4 + T cells were incubated for 1 hour prior to infection with 3,000 infectious units of CCR5-using Env pseudotyped GFP reporter virus, or 1,250 infectious units of CXCR4-using virus by spinoculation (1,200 × g for 2 h) in V-bottom 96-well tissue culture plates. We empirically determined that this virus inoculum was within the linear range of infection for the CCR5-and CXCR4-using viruses used (data not shown). Cells were then transferred to 48-well tissue culture plates and incubated for 3 days at 37 °C prior to staining with flow cytometry antibodies ( Table 1) . Flow cytometry antibodies were obtained from BD Biosciences (San Jose, CA, USA) with the exception of CD45RO eFlour450, CD122 PerCP-eFlour710 and the fixable viability dye eFlour506 which were from eBiosciences (San Diego, CA, USA). Cells were fixed for three hours in 4% (wt/vol) paraformaldehyde, then washed and resuspended in FACS buffer [filtered PBS with 2 mM EDTA and 0.5% (wt/vol) BSA]. We washed and suspended the cells in FACS buffer, as paraformaldehyde can cause changes in the emission of some fluorochromes, particularly APC-Cy7 dyes [40] . OneComp ebeads were used with the flow cytometry antibodies as compensation controls (eBiosciences).
HIV-1 infection was determined by CD3/GFP positivity and used to determine the distribution of infection within CD4 + T cell subsets, which were defined as naï ve (CD45RO [8, 21] and superior enumeration of T cell subsets, as described previously [23, 24] . TSCM were identified using methods similar to those described recently [11] .
For these analyses, >1,000,000 events were collected on a LSR Fortessa flow cytometer (BD Biosciences) and analyzed with Flowlogic software (eBiosciences). The strategy for measuring HIV-1 infection in CD4 + T cell subsets is shown in Figure 1 and Figure 4 , which are representative experiments of uninfected CD4 + T cells ( Figure 1 ) and CD4 + T cells infected with GFP reporter virus pseudotyped with 258-E-5 Env (Figure 4) , respectively.
Conclusions
We developed a novel in vitro CD4 + T cell infection assay to quantify the level and distribution of HIV-1 infection in CD4 + T cell subsets including the newly described TSCM subset. This assay was validated with CCR5-using and CXCR4-using viruses, and was able to distinguish distinct patterns of CD4 + T cell tropism associated with different co-receptor specificities. We further show that our assay can be used to measure CD4 + T cell subset infection by clinical isolates, specifically HIV-1 subtype C strains. Our assay permits the simultaneous detection and quantification of HIV-1 infection in naï ve, EMRA, TSCM, CM, TM, EM CD4 + T cell subsets. Investigation of changes in CD4 + T cell tropism by viruses isolated from longitudinal cohorts could potentially predict the establishment of viral reservoirs in vivo, and changes in cellular tropism that may be important for HIV-1 pathogenesis.
